ArticleAlzheimer's & dementia (Amsterdam, Netherlands)
Multi-modal machine learning for predicting amyloid positivity using on-ramp driving.
Article in Alzheimer's & dementia (Amsterdam, Netherlands). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Multi-modal machine learning for predicting amyloid positivity using on-ramp driving.Alzheimer's & dementia (Amsterdam, Netherlands)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
introductionEarly detection of amyloid p is critical for Alzheimer's disease (AD) risk identification. This study leverages machine learning of multi-modal attributes, including vehicular, physiological, and demographic data, to classify older adults with and without amyloid positivity.
methodsDriving data and physiological responses from 53 cognitively normal older drivers with known positron emission tomography amyloid status were collected during freeway on-ramp, merging, and post-merge stages of a fixed-course drive. Statistically significant features (
resultsIntegrating multiple data modalities (demographics, vehicular, and physiological features) improved classification performance, distinguishing amyloid status. XGBoost with all statistically significant features achieved the highest accuracy (85.1%). Vehicular data provided the most predictive power, highlighting driving behavior relevance for classification. DISCUSSION: Results underscore the importance of complementary insights from on-ramp multi-modal data to predict amyloid status and potential early AD detection. Highlights: We analyzed driving behavior and physiological signals for cognitive decline detection.Artificial intelligence (AI) models (random forest, XGBoost) effectively classified amyloid beta positive and negative participants.Interpretable AI identified on-ramp driving, that is, ZOI_1, as key for classification.Multi-modal analysis during on-ramp driving aids early cognitive decline detection.Challenging traffic environments enable non-invasive cognitive health monitoring.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.